Indication
Carcinoma of cervix
Carcinoma of the cervix is a malignant epithelial neoplasm arising from the uterine cervix, primarily occurring at the squamocolumnar junction between the ectocervix and endocervical canal. Read more about Carcinoma of cervix
31 drugs 28 manufacturers
Drugs that treat it
Common Carcinoma of cervix therapies.
KEYTRUDA POWDER (pembrolizumab)
TOPOTECAN HCL
TOPOTECAN HCL
KEYTRUDA (pembrolizumab)
TOPOTECAN HCL
HYCAMTIN (topotecan HCl)
TOPOTECAN HCL
TOPOTECAN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCarcinoma of the cervix is a malignant epithelial neoplasm arising from the uterine cervix, primarily occurring at the squamocolumnar junction between the ectocervix and endocervical canal.
Pathophysiologically driven in the vast majority of cases by persistent infection with high-risk human papillomavirus genotypes, it commonly presents histologically as squamous cell carcinoma or adenocarcinoma.
Although early stages are frequently asymptomatic and detected via routine cytological or molecular screening, advanced disease manifests with abnormal vaginal bleeding, postcoital spotting, watery or foul discharge, and pelvic pain, with the potential for direct local invasion into surrounding pelvic structures and lymphatic dissemination.
- nih.gov
Carcinoma of the cervix is a malignant epithelial neoplasm arising from the uterine cervix, primarily occurring at the squamocolumnar junction between the ectocervix and endocervical canal
- nih.gov
Carcinoma of the cervix is a malignant epithelial neoplasm arising from the uterine cervix, primarily occurring at the squamocolumnar junction between the ectocervix and endocervical canal
- nih.gov
Carcinoma of the cervix is a malignant epithelial neoplasm arising from the uterine cervix, primarily occurring at the squamocolumnar junction between the ectocervix and endocervical canal Pathophysiologically driven in the vast majority of cases by persistent infection with high-risk human papillomavirus genotypes, it commonly presents histologically as squamous cell carcinoma or adenocarcinoma Although early stages are frequently asymptomatic and detected via routine cytological or molecular s...
- nih.gov
Pathophysiologically driven in the vast majority of cases by persistent infection with high-risk human papillomavirus genotypes, it commonly presents histologically as squamous cell carcinoma or adenocarcinoma Although early stages are frequently asymptomatic and detected via routine cytological or molecular screening, advanced disease manifests with abnormal vaginal bleeding, postcoital spotting, watery or foul discharge, and pelvic pain, with the potential for direct local invasion into surrou...
- kucancercenter.org
Pathophysiologically driven in the vast majority of cases by persistent infection with high-risk human papillomavirus genotypes, it commonly presents histologically as squamous cell carcinoma or adenocarcinoma
- foundationforwomenscancer.org
Although early stages are frequently asymptomatic and detected via routine cytological or molecular screening, advanced disease manifests with abnormal vaginal bleeding, postcoital spotting, watery or foul discharge, and pelvic pain, with the potential for direct local invasion into surrounding pelvic structures and lymphatic dissemination
Personalize your experience
Follow Carcinoma of cervix and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.